Showing results (31-40 of 168) with videos related to
Sort By:
Pageof 17
European Urology Focus|March 12, 2018
Prognostic Effect of FGFR Mutations or Gene Fusions in Patients with Metastatic Urothelial Carcinoma Receiving First-line Platinum-based Chemotherapy: Results from a Large, Single-institution CohortAndrea Necchi, Salvatore Lo Vullo, Daniele Raggi, et al.Analytical and Quantitative Cytology and Histology|August 4, 2007
Leydig cell tumor and hyperplasia: a reviewMaurizio Colecchia, Manuel Nistal, Pilar Gonzalez-Peramato, et al.Bladder Cancer (Amsterdam, Netherlands)|December 31, 2016
Clinical Significance of Early Changes in Circulating Tumor Cells from Patients Receiving First-Line Cisplatin-Based Chemotherapy for Metastatic Urothelial CarcinomaEmanuela Fina, Andrea Necchi, Patrizia Giannatempo, et al.Virchows Archiv : an International Journal of Pathology|November 3, 2020
Myoid gonadal tumor. Case series, systematic review, and Bayesian analysisSalvatore Lorenzo Renne, Marina Valeri, Antonella Tosoni, et al.Human Pathology|October 17, 2003
Fibroblastic reticular cell tumor of the spleen: report of a case and review of the entityMaritza Martel, Dario Sarli, Maurizio Colecchia, et al.Anticancer Research|February 11, 2014
PSA nadir and outcome in 100 patients with pT3b prostate cancerPietro Pepe, Giuseppina Improta, Filippo Fraggetta, et al.Cancer Treatment Reviews|September 7, 2019
Collecting ducts carcinoma: An orphan disease. Literature overview and future perspectivesFilippo Pagani, Maurizio Colecchia, Pierangela Sepe, et al.Andrologia|October 18, 2021
Leiomyoadenomatoid tumours of the epididymis: A new case report and review of the literatureRoberta Lucianò, Nazario Pio Tenace, Filippo Pederzoli, et al.Journal of Experimental & Clinical Cancer Research : CR|June 10, 2024
Repositioning of antiarrhythmics for prostate cancer treatment: a novel strategy to reprogram cancer-associated fibroblasts towards a tumor-suppressive phenotypeValentina Doldi, Monica Tortoreto, Maurizio Colecchia, et al.American Journal of Clinical Pathology|December 5, 2021
Immunohistochemical Expression of Preferentially Expressed Antigen in Melanoma (PRAME) in the Uninvolved Background Testis, Germ Cell Neoplasia In Situ, and Germ Cell Tumors of the TestisCostantino Ricci, Tania Franceschini, Francesca Giunchi, et al.Pageof 17